An Advanced AIDS Patient With CD4 <20 and Plasmablastic Lymphoma Achieving Complete Response With the V-EPOCH Regimen

Plasmablastic lymphoma (PBL) is a rare form of non-Hodgkin lymphoma that is highly aggressive and carries a poor prognosis. Although the standard chemotherapy choice for most diffuse large B-cell lymphomas (DLBCL) is R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Blessie, Hong, Angelina, Iqbal, Fatima, Venkatesan, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364388/
https://www.ncbi.nlm.nih.gov/pubmed/32685310
http://dx.doi.org/10.7759/cureus.8641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364388/
https://www.ncbi.nlm.nih.gov/pubmed/32685310
http://dx.doi.org/10.7759/cureus.8641

Ejemplares similares